301509.SZ · 金凯生科
China A-shares · RS rating 32 · As of 2026-10-14
| Price | 28.00 CNY |
|---|---|
| 1-day change | -2.9% |
| RS rating (overall / 1M / 3M / 12M) | 32 / 67 / 39 / 35 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 27 / 18 / 13 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +8.8% |
| Distance from 52-week high | +40.6% |
| Market cap (USD) | $546.0M |